Young laboratory woman with testtubes

Recent News

August 2018

aTen Therapeutics has been shortlisted for Corporate LiveWire's Healthcare & Life Sciences Awards 2018, championing the best companies in their respective fields.

May 2018

Francesca Cavallaro joins aTen Therapeutics from the University of Edinburgh to undertake a 3-month work-based MSc project investigating the target of our novel antibody.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2018. All rights reserved